Lilly to Build $6B Weight-Loss Drug Factory in Alabama

Lilly to build $6B weight-loss drug factory in Alabama

This is the third of four planned U.S. manufacturing sites the pharmaceutical giant has unveiled this year, set to bring 450 factory jobs to the Huntsville area.

Eli Lilly (LLY) Stock After Hours on December 11, 2025: Retatrutide Breakthrough, $6B Plant — and What to Watch Before Friday’s Open

Eli Lilly and Company (NYSE: LLY) ended Thursday’s session back near record territory as Wall Street digested stunning new weight‑loss data from its experimental obesity drug retatrutide, a massive new U.S. manufacturing investment, and fresh signs of global expansion for its GLP‑1 franchise. As of Thursday’s close, Eli Lilly shares were trading around $1,006, up roughly 1–1.5% on the day, after swinging between an intraday high above $1,030 and…

Eli Lilly to build $6bn manufacturing facility in Alabama

The Alabama site is the third installment of four that Eli Lilly has planned for the US.